{"id":"insulin-aspart-insulin-aspart-protamin","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Lipodystrophy"}]},"_chembl":null,"_dailymed":{"setId":"5d9f0e10-edb9-4960-bd62-cf406e75bbe7","title":"INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [REMEDYREPACK INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Insulin aspart is a rapid-acting insulin analog that binds to insulin receptors on muscle and fat cells, promoting glucose uptake and lowering blood glucose quickly. The protamine-complexed component provides a longer duration of action, creating a biphasic profile that mimics physiological insulin secretion with both mealtime and basal coverage in a single injection.","oneSentence":"This is a biphasic insulin formulation combining rapid-acting insulin aspart with intermediate-acting insulin aspart protamine to provide both immediate and sustained blood glucose control.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:49:09.769Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT00657943","phase":"PHASE4","title":"The Copenhagen Insulin and Metformin Therapy Trial","status":"COMPLETED","sponsor":"Steno Diabetes Center Copenhagen","startDate":"2008-04","conditions":"Type 2 Diabetes, Atherosclerosis, Arteriosclerosis","enrollment":415}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["novomix"],"phase":"marketed","status":"active","brandName":"insulin aspart + insulin aspart protamin","genericName":"insulin aspart + insulin aspart protamin","companyName":"Steno Diabetes Center Copenhagen","companyId":"steno-diabetes-center-copenhagen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a biphasic insulin formulation combining rapid-acting insulin aspart with intermediate-acting insulin aspart protamine to provide both immediate and sustained blood glucose control. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}